The present study was designed to investigate the effects and mecha'/> Mechanisms of relaxations of bovine isolated bronchioles by the nitric oxide donor GEA 3175
首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Mechanisms of relaxations of bovine isolated bronchioles by the nitric oxide donor GEA 3175
【2h】

Mechanisms of relaxations of bovine isolated bronchioles by the nitric oxide donor GEA 3175

机译:一氧化氮供体GEA 3175释放牛分离的细支气管的机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">The present study was designed to investigate the effects and mechanisms of relaxation induced by the nitric oxide (NO) donor, GEA 3175 (a 3-aryl-substituted oxatriazole derivative) on bovine bronchioles (effective lumen diameter 200–800 μm) suspended in microvascular myographs for isometric tension recording.In segments of bovine bronchioles contracted to 5-hydroxytryptamine, GEA 3175 (10−8–10−4 M) induced concentration-dependent reproducible relaxations. These relaxations were slow in onset compared to other NO-donors such as 3-morpholinosydonimine-hydrochloride (SIN-1) and S-nitroso-N-acetylpenicillamine (SNAP).In 5-hydroxytryptamine-contracted preparations the order of relaxant potency (pD2) was: salbutamol (7.80)>GEA 3175 (6.18)>SIN-1 (4.90)>SNAP (3.55). In segments contracted to acetylcholine, the relaxant responses were reduced and GEA 3175 relaxed the bronchioles with pD2=4.41±0.12 and relaxations of 66±10% (n=4), while SNAP and salbutamol caused relaxations of 19±6% (n=4) and 27±6% (n=8) at the highest concentration used, respectively.Oxyhaemoglobin (10−5 M), the scavenger of nitric oxide, caused rightward shifts of the concentration-relaxation curves to GEA 3175 and NO. 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ, 3×10−6 M) and LY 83583 (10−6 M), the inhibitors of soluble guanylate cyclase, also reduced the relaxations induced by GEA 3175 and nitric oxide. However, ODQ did not affect salbutamol-evoked relaxation in the bovine small bronchioles.GEA 3175-induced relaxations were reduced in potassium-rich (60 mmol l−1 K+) solution. Glibenclamide (10−6 M) markedly inhibited the relaxations induced by the opener of ATP-sensitive K+ channels, levcromakalim (3×10−8–10−5 M), but it did not modify the relaxations induced by GEA 3175 or salbutamol. Apamin (5×10−7 M), a blocker of the small Ca2+-activated K+-channels did not affect the relaxations to GEA 3175. In contrast, blockers of large Ca2+-activated K+-channels, charybdotoxin (3×10−8–10−7 M) and iberiotoxin (10−8 M), did inhibit the relaxations to GEA 3175. The combination of apamin and charybdotoxin did not induce an additional inhibitory effect on the relaxations to GEA 3175 compared to charybdotoxin alone.In preparations where a concentration-response curve to GEA 3175 or NO was first obtained in the presence of LY 83583, incubation with charybdotoxin (10−7 M) did produce an additional inhibitory effect of the relaxations. However, in the presence of ODQ (3×10−6 M), iberiotoxin (10−8 M) did not produce additional reduction of the NO- or GEA 3175-induced relaxations.The present results suggest that the slow-releasing NO-donor GEA 3175 is more potent than the traditional NO donors in inducing relaxations of bovine bronchioles. GEA 3175, as for exogenously added NO, elicits relaxations through a cyclic GMP-dependent mechanism followed by opening of large conductance Ca2+-activated K+-channels.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 本研究旨在研究一氧化氮(NO)供体GEA 3175(3-芳基取代的三唑衍生物)对微血管中悬浮的牛细支气管(有效管腔直径200-800μm)诱发的松弛作用及其机制。肌电图记录等轴测张力。 在收缩成5-羟基色胺的牛细支气管中,GEA 3175(10 −8 –10 −4 M)诱导浓度依赖性的可再现松弛。与其他NO供体(例如3-吗啉代糖氨酸亚胺盐酸盐(SIN-1)和S-亚硝基-N-乙酰青霉胺(SNAP))相比,这些松弛作用起效缓慢。 在5-羟色胺收缩的制剂中松弛效力(pD2)的顺序为:沙丁胺醇(7.80)> GEA 3175(6.18)> SIN-1(4.90)> SNAP(3.55)。在与乙酰胆碱收缩的节段中,松弛反应降低,GEA 3175放松细支气管,pD2 = 4.41±0.12,松弛度为66±10%(n = 4),而SNAP和沙丁胺醇引起松弛度为19±6%(n = 4)和在最高使用浓度下分别为27±6%(n = 8)。 氧合血红蛋白(10 −5 M)是一氧化氮的清除剂,向右引起浓度-松弛曲线的偏移移至GEA 3175和NO。 1H- [1,2,4]恶二唑[4,3,-a]喹喔啉-1-酮(ODQ,3×10 -6 M)和LY 83583(10 −6 M),可溶性鸟苷酸环化酶的抑制剂,也减少了GEA 3175和一氧化氮引起的弛豫。但是,ODQ并没有影响牛细支气管中沙丁胺醇引起的舒张。 GEA 3175引起的舒张在富含钾的(60 mmol l −1 K + )解决方案。格列本脲(10 −6 M)显着抑制由ATP敏感的K + 通道左旋马卡林(3×10 −8 –10 −5 M),但它不会改变GEA 3175或沙丁胺醇引起的弛豫。 Apamin(5×10 −7 M),Ca 2 + 激活的K + 小通道的阻滞剂,不影响松弛符合GEA3175。相反,大Ca 2 + 激活的K + 通道的阻断剂charybdotoxin(3×10 -8 –10 −7 M)和埃博毒素(10 −8 M)确实抑制了GEA 3175的弛豫。木瓜蛋白酶和Charybdotoxin的组合不会诱导对GEA 3175的额外抑制作用。与单独的Charybdotoxin相比,GEA 3175的浓度降低。 在LY 83583存在的情况下首次获得对GEA 3175或NO的浓度-响应曲线的制剂中,与charybdotoxin(10 -7 <确实产生了额外的松弛抑制作用。但是,在存在ODQ(3×10 -6 M)的情况下,埃博毒素(10 -8 M)不会产生NO-或GEA 3175-的进一步还原。 目前的结果表明,缓慢释放的NO供体GEA 3175在诱导牛细支气管松弛方面比传统的NO供体更有效。对于外源添加的NO,GEA 3175通过循环GMP依赖性机制引起弛豫,随后打开大电导Ca 2 + 激活的K + 通道。 li>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号